NCT04399213View on ClinicalTrials.gov

Dermal Blood Flow Response to Escalating Doses of Histamine, Administered by a Skin Prick

NACompletedINTERVENTIONAL
Enrollment

13

Participants

Timeline

Start Date

January 15, 2019

Primary Completion Date

February 19, 2019

Study Completion Date

February 19, 2019

Conditions
Pruritus
Interventions
PROCEDURE

50 µg Histamine

Skin prick through 50 µg/5 µL histamine diHCl

PROCEDURE

15 µg Histamine

Skin prick through 15 µg/5 µL histamine diHCl

PROCEDURE

5 µg Histamine

Skin prick through 5 µg/5 µL histamine diHCl

PROCEDURE

Placebo (saline)

Skin prick through 5 µL saline (0.9% NaCl)

Trial Locations (1)

3000

Center for Clinical Pharmacology, Leuven

All Listed Sponsors
lead

Universitaire Ziekenhuizen KU Leuven

OTHER

NCT04399213 - Dermal Blood Flow Response to Escalating Doses of Histamine, Administered by a Skin Prick | Biotech Hunter | Biotech Hunter